Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""FOXM1"" wg kryterium: Temat


Tytuł:
FOXM1: a new therapeutic target of extramammary Paget disease.
Autorzy:
Ito T; Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. .
Tanaka Y; Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Kaku-Ito Y; Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Oda Y; Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, 812-8582, Japan.
Nakahara T; Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 19; Vol. 14 (1), pp. 4048. Date of Electronic Publication: 2024 Feb 19.
Typ publikacji:
Journal Article
MeSH Terms:
Forkhead Box Protein M1*/genetics
Forkhead Box Protein M1*/metabolism
Paget Disease, Extramammary*/genetics
Paget Disease, Extramammary*/pathology
Humans ; Cell Line, Tumor ; Thiostrepton/pharmacology ; Treatment Outcome
Czasopismo naukowe
Tytuł:
The Promise of Combination Therapies with FOXM1 Inhibitors for Cancer Treatment.
Autorzy:
Merjaneh N; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ 85016, USA.; Department of Child Health, Division of Hematology and Oncology, The University of Arizona College of Medicine-Phoenix, Phoenix, AZ 85004, USA.
Hajjar M; The Columbian College of Arts and Sciences, George Washington University, Washington, DC 20052, USA.
Lan YW; Phoenix Children's Research Institute, The University of Arizona College of Medicine-Phoenix, Phoenix, AZ 85004, USA.
Kalinichenko VV; Phoenix Children's Research Institute, The University of Arizona College of Medicine-Phoenix, Phoenix, AZ 85004, USA.; Division of Neonatology, Phoenix Children's Hospital, Phoenix, AZ 85016, USA.
Kalin TV; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ 85016, USA.; Department of Child Health, Division of Hematology and Oncology, The University of Arizona College of Medicine-Phoenix, Phoenix, AZ 85004, USA.; Phoenix Children's Research Institute, The University of Arizona College of Medicine-Phoenix, Phoenix, AZ 85004, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2024 Feb 12; Vol. 16 (4). Date of Electronic Publication: 2024 Feb 12.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Tytuł:
FOXM1 Participates in Trophoblast Migration and Early Trophoblast Invasion: Potential Role in Blastocyst Implantation.
Autorzy:
Peñailillo R; Program in Biology of Reproduction, Center for Biomedical Research and Innovation (CiiB), Universidad de los Andes, Santiago 7620001, Chile.; IMPACT, Center of Interventional Medicine for Precision and Advanced Cellular Therapy, Santiago 7620001, Chile.
Velásquez V; Program in Biology of Reproduction, Center for Biomedical Research and Innovation (CiiB), Universidad de los Andes, Santiago 7620001, Chile.
Acuña-Gallardo S; Program in Biology of Reproduction, Center for Biomedical Research and Innovation (CiiB), Universidad de los Andes, Santiago 7620001, Chile.; IMPACT, Center of Interventional Medicine for Precision and Advanced Cellular Therapy, Santiago 7620001, Chile.; School of Medicine, Faculty of Medicine, Universidad de los Andes, Santiago 7620001, Chile.
García F; Program in Biology of Reproduction, Center for Biomedical Research and Innovation (CiiB), Universidad de los Andes, Santiago 7620001, Chile.; IMPACT, Center of Interventional Medicine for Precision and Advanced Cellular Therapy, Santiago 7620001, Chile.
Sánchez M; Program in Neuroscience, Centre for Biomedical Research and Innovation (CiiB), Universidad de los Andes, Santiago 7620001, Chile.
Nardocci G; IMPACT, Center of Interventional Medicine for Precision and Advanced Cellular Therapy, Santiago 7620001, Chile.; School of Medicine, Faculty of Medicine, Universidad de los Andes, Santiago 7620001, Chile.; Molecular Biology and Bioinformatics Lab, Program in Molecular Biology and Bioinformatics, Centre for Biomedical Research and Innovation (CiiB), Universidad de los Andes, Santiago 7620001, Chile.
Illanes SE; Program in Biology of Reproduction, Center for Biomedical Research and Innovation (CiiB), Universidad de los Andes, Santiago 7620001, Chile.; IMPACT, Center of Interventional Medicine for Precision and Advanced Cellular Therapy, Santiago 7620001, Chile.; School of Medicine, Faculty of Medicine, Universidad de los Andes, Santiago 7620001, Chile.
Monteiro LJ; Program in Biology of Reproduction, Center for Biomedical Research and Innovation (CiiB), Universidad de los Andes, Santiago 7620001, Chile.; IMPACT, Center of Interventional Medicine for Precision and Advanced Cellular Therapy, Santiago 7620001, Chile.; School of Medicine, Faculty of Medicine, Universidad de los Andes, Santiago 7620001, Chile.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 30; Vol. 25 (3). Date of Electronic Publication: 2024 Jan 30.
Typ publikacji:
Journal Article
MeSH Terms:
Forkhead Box Protein M1*/genetics
Forkhead Box Protein M1*/metabolism
Placenta*/metabolism
Trophoblasts*/metabolism
Animals ; Female ; Humans ; Mice ; Pregnancy ; Rats ; Cell Movement ; Embryo Implantation ; Oxygen/metabolism ; Protein Serine-Threonine Kinases/metabolism
Czasopismo naukowe
Tytuł:
OTUD7B knockdown inhibits the proliferation and stemness of breast cancer cells by destabilizing FOXM1.
Autorzy:
Wang H; Department of Breast Surgery, Sanming First Hospital Affiliated to Fujian Medical University, Sanming, Fujian 365000, P.R. China.
Han S; Department of Dermatology, Sanming First Hospital Affiliated to Fujian Medical University, Sanming, Fujian 365000, P.R. China.
Xiao J; Department of Breast Surgery, Sanming First Hospital Affiliated to Fujian Medical University, Sanming, Fujian 365000, P.R. China.
Fu X; Department of Breast Surgery, Sanming First Hospital Affiliated to Fujian Medical University, Sanming, Fujian 365000, P.R. China.
Chen W; Department of Dermatology, Sanming First Hospital Affiliated to Fujian Medical University, Sanming, Fujian 365000, P.R. China.
Zhuo D; Department of Laboratory Medicine, Sanming First Hospital Affiliated to Fujian Medical University, Sanming, Fujian 365000, P.R. China.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2024 Jan 16; Vol. 27 (3), pp. 102. Date of Electronic Publication: 2024 Jan 16 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Invasive FoxM1 phosphorylated by PLK1 induces the polarization of tumor-associated macrophages to promote immune escape and metastasis, amplified by IFITM1.
Autorzy:
Xu R; Department of Pharmacy, College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-Do, 15588, Republic of Korea.
Lee YJ; Department of Pharmacy, College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-Do, 15588, Republic of Korea.
Kim CH; Department of Pharmacy, College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-Do, 15588, Republic of Korea.
Min GH; Department of Pharmacy, College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-Do, 15588, Republic of Korea.
Kim YB; Department of Pharmacy, College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-Do, 15588, Republic of Korea.
Park JW; Department of Pharmacy, College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-Do, 15588, Republic of Korea.
Kim DH; Department of Pharmacy, College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-Do, 15588, Republic of Korea.
Kim JH; Division of Intractable Diseases Research, Department of Chronic Diseases Convergence Research, Korea National Institute of Health, Cheongju, Chungcheongbuk-Do, 28160, Republic of Korea.
Yim H; Department of Pharmacy, College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-Do, 15588, Republic of Korea. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Nov 16; Vol. 42 (1), pp. 302. Date of Electronic Publication: 2023 Nov 16.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*
Lung Neoplasms*/genetics
Animals ; Mice ; Humans ; Forkhead Transcription Factors/metabolism ; Forkhead Box Protein M1/genetics ; Tumor-Associated Macrophages/metabolism ; Chromatography, Liquid ; Tandem Mass Spectrometry ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
FOXM1 and CENPF are associated with a poor prognosis through promoting proliferation and migration in lung adenocarcinoma.
Autorzy:
Li P; The First Department of Pulmonary and Critical Care Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China.; Hebei Key Laboratory of Respiratory Critical Care Medicine, The First Department of Pulmonary and Critical Care Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China.; Department of Pulmonary and Critical Care Medicine, Hengshui People's Hospital, Hengshui, Hebei 053000, P.R. China.
Ma G; Department of Gastroenterology, Hengshui People's Hospital, Hengshui, Hebei 053000, P.R. China.
Cui Z; Department of Pulmonary and Critical Care Medicine, Hengshui People's Hospital, Hengshui, Hebei 053000, P.R. China.
Zhang S; The First Department of Pulmonary and Critical Care Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China.; Hebei Key Laboratory of Respiratory Critical Care Medicine, The First Department of Pulmonary and Critical Care Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China.; Department of Pulmonary and Critical Care Medicine, Affiliated Xing Tai People Hospital of Hebei Medical University, Xingtai, Hebei 054001, P.R. China.
Su Q; The First Department of Pulmonary and Critical Care Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China.; Hebei Key Laboratory of Respiratory Critical Care Medicine, The First Department of Pulmonary and Critical Care Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China.
Cai Z; The First Department of Pulmonary and Critical Care Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China.; Hebei Key Laboratory of Respiratory Critical Care Medicine, The First Department of Pulmonary and Critical Care Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2023 Oct 17; Vol. 26 (6), pp. 518. Date of Electronic Publication: 2023 Oct 17 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
LRPPRC regulates malignant behaviors, protects mitochondrial homeostasis, mitochondrial function in osteosarcoma and derived cancer stem-like cells.
Autorzy:
Zhao Z; TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610041, P.R. China.
Sun Y; Department of Pharmacy, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610041, P.R. China.
Tang J; Chongqing Three gorges medical college, Chongqing, 404120, P.R. China.
Yang Y; TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610041, P.R. China.
Xu X; College of Food and Biological Engineering, Chengdu University, Chengdu, 610000, P.R. China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Oct 03; Vol. 23 (1), pp. 935. Date of Electronic Publication: 2023 Oct 03.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Neoplasms*/pathology
Esophageal Squamous Cell Carcinoma*/pathology
Osteosarcoma*/pathology
Lung Neoplasms*/pathology
Bone Neoplasms*/pathology
Humans ; Reactive Oxygen Species/metabolism ; Mitochondria/metabolism ; Homeostasis ; Cell Line, Tumor ; Cell Proliferation ; Neoplastic Stem Cells/metabolism ; Neoplasm Proteins/genetics
Czasopismo naukowe
Tytuł:
FOXM1, MEK, and CDK4/6: New Targets for Malignant Peripheral Nerve Sheath Tumor Therapy.
Autorzy:
Voigt E; Cancer Biology Graduate Program, University of Iowa, Iowa City, IA 52242, USA.; Medical Scientist Training Program, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA 52242, USA.
Quelle DE; Cancer Biology Graduate Program, University of Iowa, Iowa City, IA 52242, USA.; Medical Scientist Training Program, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA 52242, USA.; Department of Neuroscience and Pharmacology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.; Department of Pathology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Sep 02; Vol. 24 (17). Date of Electronic Publication: 2023 Sep 02.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Neurofibromatosis 1*
Neurofibrosarcoma*
Sarcoma*
Adolescent ; Humans ; Cyclin-Dependent Kinase 4/genetics ; Forkhead Box Protein M1/genetics ; Mitogen-Activated Protein Kinase Kinases ; Oncogenes
Czasopismo naukowe
Tytuł:
FOXM1a Isoform of Oncogene FOXM1 Is a Tumor Suppressor Suppressed by hnRNP C in Oral Squamous Cell Carcinoma.
Autorzy:
Jia R; State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan 430072, China.
Che X; State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan 430072, China.
Jia J; State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan 430072, China.; Department of Oral and Maxillofacial Surgery, School & Hospital of Stomatology, Wuhan University, Wuhan 430072, China.
Guo J; State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan 430072, China.; Department of Endodontics, School & Hospital of Stomatology, Wuhan University, Wuhan 430072, China.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2023 Aug 30; Vol. 13 (9). Date of Electronic Publication: 2023 Aug 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Heterogeneous-Nuclear Ribonucleoprotein Group C*/genetics
Heterogeneous-Nuclear Ribonucleoprotein Group C*/metabolism
Mouth Neoplasms*/genetics
Squamous Cell Carcinoma of Head and Neck*/genetics
Forkhead Box Protein M1*/genetics
Forkhead Box Protein M1*/metabolism
Animals ; Mice ; Alternative Splicing ; Mice, Nude ; Oncogenes ; Protein Isoforms/genetics ; Protein Isoforms/metabolism ; Humans
Czasopismo naukowe
Tytuł:
A co-formulation of interferons alpha2b and gamma distinctively targets cell cycle in the glioblastoma-derived cell line U-87MG.
Autorzy:
Miranda J; Bioinformatics Group, Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba. .
Vázquez-Blomquist D; Pharmacogenomics Group, Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba. .
Bringas R; Bioinformatics Group, Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba.
Fernandez-de-Cossio J; Bioinformatics Group, Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba.
Palenzuela D; Pharmacogenomics Group, Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba.
Novoa LI; Pharmacogenomics Group, Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba.
Bello-Rivero I; Clinical Assays Division, Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Aug 29; Vol. 23 (1), pp. 806. Date of Electronic Publication: 2023 Aug 29.
Typ publikacji:
Journal Article
MeSH Terms:
Glioblastoma*/drug therapy
Glioblastoma*/genetics
Skin Neoplasms*
Humans ; Apoptosis ; Cell Line, Tumor ; G2 Phase Cell Cycle Checkpoints ; Interferon-alpha/pharmacology ; Anaphase ; Interferon-gamma/pharmacology
Czasopismo naukowe
Tytuł:
The development of an anti-cancer peptide M1-21 targeting transcription factor FOXM1.
Autorzy:
Cheng H; State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Biology, Hunan Engineering Research Center for Anticancer Targeted Protein Pharmaceuticals, Hunan University, 410082, Changsha, Hunan, China.
Yuan J; State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Biology, Hunan Engineering Research Center for Anticancer Targeted Protein Pharmaceuticals, Hunan University, 410082, Changsha, Hunan, China.
Pei C; State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Biology, Hunan Engineering Research Center for Anticancer Targeted Protein Pharmaceuticals, Hunan University, 410082, Changsha, Hunan, China.
Ouyang M; State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Biology, Hunan Engineering Research Center for Anticancer Targeted Protein Pharmaceuticals, Hunan University, 410082, Changsha, Hunan, China.
Bu H; State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Biology, Hunan Engineering Research Center for Anticancer Targeted Protein Pharmaceuticals, Hunan University, 410082, Changsha, Hunan, China.
Chen Y; State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Biology, Hunan Engineering Research Center for Anticancer Targeted Protein Pharmaceuticals, Hunan University, 410082, Changsha, Hunan, China.
Huang X; State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Biology, Hunan Engineering Research Center for Anticancer Targeted Protein Pharmaceuticals, Hunan University, 410082, Changsha, Hunan, China.
Zhang Z; State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Biology, Hunan Engineering Research Center for Anticancer Targeted Protein Pharmaceuticals, Hunan University, 410082, Changsha, Hunan, China. .; Medicine Research Institute, Hubei Key Laboratory of Diabetes and Angiopathy, Xianning Medical College, Hubei University of Science and Technology, 437000, Xianning, Hubei, China. .
Yu L; State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Biology, Hunan Engineering Research Center for Anticancer Targeted Protein Pharmaceuticals, Hunan University, 410082, Changsha, Hunan, China. .
Tan Y; State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Biology, Hunan Engineering Research Center for Anticancer Targeted Protein Pharmaceuticals, Hunan University, 410082, Changsha, Hunan, China. .
Pokaż więcej
Źródło:
Cell & bioscience [Cell Biosci] 2023 Jun 21; Vol. 13 (1), pp. 114. Date of Electronic Publication: 2023 Jun 21.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
HMGA1 and FOXM1 Cooperate to Promote G2/M Cell Cycle Progression in Cancer Cells.
Autorzy:
Zheng Q; Institute of Biochemistry and Molecular Biology, Basic Medical Sciences, Health Science Center, Ningbo University, Ningbo 315211, China.
Luo Z; Institute of Biochemistry and Molecular Biology, Basic Medical Sciences, Health Science Center, Ningbo University, Ningbo 315211, China.
Xu M; Institute of Biochemistry and Molecular Biology, Basic Medical Sciences, Health Science Center, Ningbo University, Ningbo 315211, China.
Ye S; Institute of Biochemistry and Molecular Biology, Basic Medical Sciences, Health Science Center, Ningbo University, Ningbo 315211, China.
Lei Y; Institute of Biochemistry and Molecular Biology, Basic Medical Sciences, Health Science Center, Ningbo University, Ningbo 315211, China.
Xi Y; Institute of Biochemistry and Molecular Biology, Basic Medical Sciences, Health Science Center, Ningbo University, Ningbo 315211, China.
Pokaż więcej
Źródło:
Life (Basel, Switzerland) [Life (Basel)] 2023 May 22; Vol. 13 (5). Date of Electronic Publication: 2023 May 22.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
FOXM1: Functional Roles of FOXM1 in Non-Malignant Diseases.
Autorzy:
Zhang Z; Hubei Key Laboratory of Diabetes and Angiopathy, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, China.
Li M; School of Nuclear Technology and Chemistry & Biology, Hubei University of Science and Technology, Xianning 437100, China.
Sun T; Hubei Key Laboratory of Diabetes and Angiopathy, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, China.; Medical Research Institute, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, China.
Zhang Z; Hubei Key Laboratory of Diabetes and Angiopathy, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, China.; Medical Research Institute, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, China.
Liu C; Hubei Key Laboratory of Diabetes and Angiopathy, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, China.; Medical Research Institute, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, China.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2023 May 18; Vol. 13 (5). Date of Electronic Publication: 2023 May 18.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Forkhead Box Protein M1*/genetics
Forkhead Box Protein M1*/metabolism
Pulmonary Fibrosis*
Animals ; Humans ; beta Catenin/metabolism ; Cell Proliferation
Czasopismo naukowe
Tytuł:
Morin Sensitizes MDA-MB-231 Triple-Negative Breast Cancer Cells to Doxorubicin Cytotoxicity by Suppressing FOXM1 and Attenuating EGFR/STAT3 Signaling Pathways.
Autorzy:
Maharjan S; Department of Pharmacology, College of Medicine and Intractable Disease Research Center, Dongguk University, Gyeongju 38066, Republic of Korea.
Lee MG; Department of Pharmacology, College of Medicine and Intractable Disease Research Center, Dongguk University, Gyeongju 38066, Republic of Korea.
Kim SY; Department of Pharmacology, College of Medicine and Intractable Disease Research Center, Dongguk University, Gyeongju 38066, Republic of Korea.
Lee KS; Department of Pharmacology, College of Medicine and Intractable Disease Research Center, Dongguk University, Gyeongju 38066, Republic of Korea.
Nam KS; Department of Pharmacology, College of Medicine and Intractable Disease Research Center, Dongguk University, Gyeongju 38066, Republic of Korea.
Pokaż więcej
Źródło:
Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2023 Apr 29; Vol. 16 (5). Date of Electronic Publication: 2023 Apr 29.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Overexpression of FoxM1 optimizes the therapeutic effect of bone marrow mesenchymal stem cells on acute respiratory distress syndrome.
Autorzy:
Luo Y; Department of Medical Intensive Care Unit, The First Affiliated Hospital, Sun Yat-Sen University, No.58 Zhongshan Road 2, Guangzhou, 510080, Guangdong, China.
Ge S; Department of Medical Intensive Care Unit, The First Affiliated Hospital, Sun Yat-Sen University, No.58 Zhongshan Road 2, Guangzhou, 510080, Guangdong, China.
Chen Q; Department of Medical Intensive Care Unit, The First Affiliated Hospital, Sun Yat-Sen University, No.58 Zhongshan Road 2, Guangzhou, 510080, Guangdong, China.
Lin S; Department of Medical Intensive Care Unit, The First Affiliated Hospital, Sun Yat-Sen University, No.58 Zhongshan Road 2, Guangzhou, 510080, Guangdong, China.
He W; Department of Medical Intensive Care Unit, The First Affiliated Hospital, Sun Yat-Sen University, No.58 Zhongshan Road 2, Guangzhou, 510080, Guangdong, China.
Zeng M; Department of Medical Intensive Care Unit, The First Affiliated Hospital, Sun Yat-Sen University, No.58 Zhongshan Road 2, Guangzhou, 510080, Guangdong, China. .
Pokaż więcej
Źródło:
Stem cell research & therapy [Stem Cell Res Ther] 2023 Feb 14; Vol. 14 (1), pp. 27. Date of Electronic Publication: 2023 Feb 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lung Injury*
Mesenchymal Stem Cells*/metabolism
Respiratory Distress Syndrome*/therapy
Forkhead Box Protein M1*/genetics
Animals ; Mice ; beta Catenin/metabolism ; Bone Marrow Cells ; Cytokines/metabolism ; Endothelial Cells/metabolism ; Lipopolysaccharides/toxicity
Czasopismo naukowe
Tytuł:
MicroRNA-1 attenuates the growth and metastasis of small cell lung cancer through CXCR4/FOXM1/RRM2 axis.
Autorzy:
Khan P; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Siddiqui JA; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Kshirsagar PG; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Venkata RC; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Maurya SK; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Mirzapoiazova T; Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA, 91010, USA.
Perumal N; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Chaudhary S; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Kanchan RK; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Fatima M; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Khan MA; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Rehman AU; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Lakshmanan I; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Mahapatra S; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, 68198, USA.; Department of Pediatrics, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Talmon GA; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Kulkarni P; Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA, 91010, USA.
Ganti AK; Division of Oncology-Hematology, Department of Internal Medicine, VA-Nebraska Western Iowa Health Care System, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Jain M; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Salgia R; Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA, 91010, USA.
Batra SK; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, 68198, USA.; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Nasser MW; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA. .; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, 68198, USA. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2023 Jan 04; Vol. 22 (1), pp. 1. Date of Electronic Publication: 2023 Jan 04.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Small Cell Lung Carcinoma*/genetics
Small Cell Lung Carcinoma*/pathology
MicroRNAs*/genetics
MicroRNAs*/metabolism
Lung Neoplasms*/pathology
Humans ; Animals ; Mice ; Cell Line, Tumor ; Cell Proliferation/genetics ; Gene Expression Regulation, Neoplastic ; Forkhead Box Protein M1/genetics ; Receptors, CXCR4/genetics ; Receptors, CXCR4/metabolism
Czasopismo naukowe
Tytuł:
Multiplexed immunofluorescence analysis of CAF-markers, EZH2 and FOXM1 in gastric tissue: associations with clinicopathological parameters and clinical outcomes.
Autorzy:
Sun H; Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Wang X; Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Zhang X; Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Wang X; Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Institute of Pathology, Fudan University, Shanghai, 200032, China.
Tan C; Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Institute of Pathology, Fudan University, Shanghai, 200032, China.
Weng W; Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Institute of Pathology, Fudan University, Shanghai, 200032, China.
Zhang M; Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Institute of Pathology, Fudan University, Shanghai, 200032, China.
Ni S; Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Institute of Pathology, Fudan University, Shanghai, 200032, China.
Wang L; Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Institute of Pathology, Fudan University, Shanghai, 200032, China.
Huang D; Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Institute of Pathology, Fudan University, Shanghai, 200032, China.
Xu M; Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai, 200032, China. .; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. .; Institute of Pathology, Fudan University, Shanghai, 200032, China. .
Sheng W; Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai, 200032, China. .; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. .; Institute of Pathology, Fudan University, Shanghai, 200032, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2022 Nov 18; Vol. 22 (1), pp. 1188. Date of Electronic Publication: 2022 Nov 18.
Typ publikacji:
Journal Article
MeSH Terms:
Stomach Neoplasms*/pathology
Humans ; Prognosis ; Fluorescent Antibody Technique ; Biomarkers ; Enhancer of Zeste Homolog 2 Protein/metabolism ; Forkhead Box Protein M1
Czasopismo naukowe
Tytuł:
Forkhead box M1 recruits FoxP3 Treg cells to induce immune escape in hilar cholangiocarcinoma.
Autorzy:
Ma K; Department of General Surgery, Shandong Qianfoshan Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province, P.R. China.
Sun Z; Department of Hepatopancreatobiliary Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, P.R. China.
Li X; Department of Hepatopancreatobiliary Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, P.R. China.
Guo J; Department of Hepatopancreatobiliary Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, P.R. China.
Wang Q; Department of Hepatopancreatobiliary Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, P.R. China.
Teng M; Department of General Surgery, Shandong Qianfoshan Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province, P.R. China.
Pokaż więcej
Źródło:
Immunity, inflammation and disease [Immun Inflamm Dis] 2022 Nov; Vol. 10 (11), pp. e727.
Typ publikacji:
Journal Article
MeSH Terms:
Klatskin Tumor*/metabolism
Klatskin Tumor*/pathology
Bile Duct Neoplasms*/genetics
Bile Duct Neoplasms*/metabolism
Bile Duct Neoplasms*/pathology
Humans ; Mice ; Animals ; T-Lymphocytes, Regulatory ; CD8-Positive T-Lymphocytes ; Forkhead Transcription Factors/genetics ; Transforming Growth Factor beta/metabolism
Czasopismo naukowe
Tytuł:
Identification of new small molecules as dual FoxM1 and Hsp70 inhibitors using computational methods.
Autorzy:
Alimardan Z; Department of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.; Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.
Abbasi M; Department of Medicinal Chemistry, Faculty of Pharmacy, Hormozgan University of Medical Sciences, Bandar Abbas, I.R. Iran.
Khodarahmi G; Department of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.; Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.
Kashfi K; Department of Molecular, Cellular, and Biomedical Sciences, Sophie Davis School of Biomedical Education, City University of New York School of Medicine, New York, USA.; Graduate Program in Biology, City University of New York Graduate Center, New York, USA.; Department of Chemistry and Physics, State University of New York at Old Westbury, New York, USA.
Hasanzadeh F; Department of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.
Mahmud A; Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.; Department of Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.
Pokaż więcej
Źródło:
Research in pharmaceutical sciences [Res Pharm Sci] 2022 Oct 29; Vol. 17 (6), pp. 635-656. Date of Electronic Publication: 2022 Oct 29 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Characterizing and Targeting Genes Regulated by Transcription Factor MYBL2 in Lung Adenocarcinoma Cells.
Autorzy:
Lee Y; Department of Biochemistry and Molecular Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Wu Z; Department of Biochemistry and Molecular Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Yang S; Department of Biochemistry and Molecular Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Schreiner SM; Department of Biochemistry and Molecular Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Gonzalez-Smith LD; Department of Biochemistry and Molecular Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Rhie SK; Department of Biochemistry and Molecular Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Oct 11; Vol. 14 (20). Date of Electronic Publication: 2022 Oct 11.
Typ publikacji:
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies